Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.190
-0.180 (-4.12%)
At close: Jun 17, 2026, 4:00 PM EDT
4.270
+0.080 (1.91%)
After-hours: Jun 17, 2026, 5:55 PM EDT
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $195.21 million as of June 17, 2026. Its market cap has increased by 1,487.05% in one year.
Market Cap
195.21M
Enterprise Value
177.14M
1-Year Change
1,487.05%
Ranking
Category
Stock Price
$4.19
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has increased from $110.60M to $195.21M, an increase of 76.50%. That is a compound annual growth rate of 4.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 195.21M | 594.69% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cybin | 214.65M |
| Camp4 Therapeutics | 214.45M |
| Protara Therapeutics | 214.14M |
| Voyager Therapeutics | 213.29M |
| Coherus Oncology | 212.86M |
| NervGen Pharma | 212.41M |
| Whitehawk Therapeutics | 206.22M |
| Karyopharm Therapeutics | 205.22M |